|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Cash, cash equivalents and restricted cash | ||||||||||||||||||||
| Loans, net of allowance for loan losses of $1,478,188 in 2018 and $1,827,806 in 2017 | ||||||||||||||||||||
| Interest and other receivables | ||||||||||||||||||||
| Other assets, net of accumulated depreciation and amortization of $85,944 in 2018 and $309,686 in 2017 | ||||||||||||||||||||
| Deferred financing costs, net of accumulated amortization of $828,433 in 2015 and $253,675 in 2014 | ||||||||||||||||||||
| Deferred financing costs, net of accumulated amortization of $82,635 in 2018 and $265,276 in 2017 | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Investment in limited liability company | ||||||||||||||||||||
| Real estate held for sale | ||||||||||||||||||||
| Real estate held for investment, net of accumulated depreciation of $2,679,823 in 2018 and $3,316,753 in 2017 | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Due to Manager | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Deferred gains | ||||||||||||||||||||
| Forward contract liability – share repurchase | ||||||||||||||||||||
| Line of credit payable | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Notes and loans payable on real estate | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Common stock, $.01 par value per share, 50,000,000 shares authorized, 11,198,119 shares issued, 8,482,880 and 9,095,454 shares outstanding at December 31, 2018 and 2017 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost – 2,715,239 and 2,102,665 shares at December 31, 2018 and 2017 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
